MR1-restricted MAIT-cell population in chronic HIV-1 infection Activation, exhaustion, and persistent decline of the antimicrobial

[1]  Malcolm J. McConville,et al.  MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.

[2]  D. Hoft,et al.  Polyclonal Mucosa-Associated Invariant T Cells Have Unique Innate Functions in Bacterial Infection , 2012, Infection and Immunity.

[3]  P. Streeter,et al.  Human thymic MR1-restricted MAIT cells are innate pathogen-reactive effectors that adapt following thymic egress , 2012, Mucosal Immunology.

[4]  James McCluskey,et al.  Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor , 2012, The Journal of experimental medicine.

[5]  D. Douek,et al.  Microbial translocation across the GI tract. , 2012, Annual review of immunology.

[6]  S. Girardin,et al.  Innate IL-17 and IL-22 responses to enteric bacterial pathogens. , 2012, Trends in immunology.

[7]  P. Klenerman,et al.  Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. , 2012, Blood.

[8]  A. Haase,et al.  Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy , 2012, PLoS pathogens.

[9]  T. Dong,et al.  Induction of Lectin-like Transcript 1 (LLT1) Protein Cell Surface Expression by Pathogens and Interferon-γ Contributes to Modulate Immune Responses* , 2011, The Journal of Biological Chemistry.

[10]  T. Yamamura,et al.  Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. , 2011, International immunology.

[11]  Handan Wand,et al.  Plasma levels of soluble CD14 independently predict mortality in HIV infection. , 2011, The Journal of infectious diseases.

[12]  J. Carlis,et al.  Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. , 2011, The Journal of clinical investigation.

[13]  P. Georgel,et al.  The non-conventional MHC class I MR1 molecule controls infection by Klebsiella pneumoniae in mice. , 2011, Molecular immunology.

[14]  O. Lantz,et al.  Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. , 2011, Blood.

[15]  S. Deeks,et al.  HIV infection, inflammation, immunosenescence, and aging. , 2011, Annual review of medicine.

[16]  M. Moll,et al.  Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. , 2010, Blood.

[17]  O. Lantz,et al.  Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.

[18]  J. Chmiel,et al.  AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study , 2010, AIDS.

[19]  Matthew S. Cook,et al.  Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells , 2010, PLoS biology.

[20]  A. Landay,et al.  Early Immune Senescence in HIV Disease , 2010, Current HIV/AIDS reports.

[21]  D. Fremont,et al.  MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution , 2009, Proceedings of the National Academy of Sciences.

[22]  M. Lederman,et al.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. , 2009, The Journal of infectious diseases.

[23]  Veronica D. Gonzalez,et al.  Severe functional impairment and elevated PD‐1 expression in CD1d‐restricted NKT cells retained during chronic HIV‐1 infection , 2009, European journal of immunology.

[24]  O. Lantz,et al.  Stepwise Development of MAIT Cells in Mouse and Human , 2009, PLoS biology.

[25]  J. Margolick,et al.  Immune activation and IL‐12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy , 2008, Journal of Leukocyte Biology.

[26]  H. Sørensen,et al.  Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Michael D. George,et al.  Rapid Onset of Intestinal Epithelial Barrier Dysfunction in Primary Human Immunodeficiency Virus Infection Is Driven by an Imbalance between Immune Response and Mucosal Repair and Regeneration , 2007, Journal of Virology.

[28]  B. Autran,et al.  Accelerated immune senescence and HIV-1 infection , 2007, Experimental Gerontology.

[29]  A. Sönnerborg,et al.  Early immune activation in gut-associated and peripheral lymphoid tissue during acute HIV infection , 2007, AIDS.

[30]  S. Crowe,et al.  The Mechanism Underlying Defective Fcγ Receptor-Mediated Phagocytosis by HIV-1-Infected Human Monocyte-Derived Macrophages1 , 2007, The Journal of Immunology.

[31]  M. Lederman,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Nature Medicine.

[32]  Daniel Doischer,et al.  Impaired complement-mediated phagocytosis by HIV type-1-infected human monocyte-derived macrophages involves a cAMP-dependent mechanism. , 2006, AIDS research and human retroviruses.

[33]  S. Gilfillan,et al.  MR1-Restricted Vα19i Mucosal-Associated Invariant T Cells Are Innate T Cells in the Gut Lamina Propria That Provide a Rapid and Diverse Cytokine Response1 , 2006, The Journal of Immunology.

[34]  F. Bihl,et al.  Cutting Edge: Lectin-Like Transcript 1 Is a Ligand for the CD161 Receptor1 , 2005, The Journal of Immunology.

[35]  C. Pradier,et al.  In the era of highly active antiretroviral therapy, why are HIV‐infected patients still admitted to hospital for an inaugural opportunistic infection? , 2005, HIV medicine.

[36]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[37]  C. Sabin,et al.  Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy , 2004, AIDS.

[38]  D. Price,et al.  CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[39]  Christine Hogan,et al.  Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[40]  D. Nixon,et al.  Abundant Expression of Granzyme A, but Not Perforin, in Granules of CD8+ T Cells in GALT: Implications for Immune Control of HIV-1 Infection1 , 2004, The Journal of Immunology.

[41]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[42]  Julie Elliott,et al.  Optimization of methods to assess human mucosal T-cell responses to HIV infection. , 2003, Journal of immunological methods.

[43]  Olivier Lantz,et al.  Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.

[44]  C. Macken,et al.  Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects , 2003, AIDS.

[45]  Katherine Kedzierska,et al.  HIV-1 Down-Modulates γ Signaling Chain of FcγR in Human Macrophages: A Possible Mechanism for Inhibition of Phagocytosis1 , 2002, The Journal of Immunology.

[46]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[47]  F. Lemonnier,et al.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein , 1996, Nature Medicine.